Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 13, 2026
JPMorgan Chase (JPM) Q2 2026 Earnings Preview: Analysts Project +9.7% EPS Growth

JPMorgan Chase (JPM) Q2 2026 Earnings Preview: Analysts Project +9.7% EPS Growth

Key Takeaways

  • JPMorgan Chase is set to report second-quarter 2026 results before market open on July 14, 2026.
  • Analysts estimate earnings per share of $5.44, representing a 9.7% increase from $4.96 in the year-ago quarter.
  • Investors will focus on net interest income trends, loan growth, and credit quality metrics.
  • Revenue expectations center on continued strength in consumer and corporate banking segments.
  • The bank has beaten earnings estimates in the prior four quarters.
  • Guidance updates and management commentary on interest rates and economic conditions will be closely watched.

Why JPMorgan's Results Matter

JPMorgan Chase & Co. is the largest U.S. bank by assets and a bellwether for the financial sector. Its quarterly results provide critical insights into consumer spending, corporate borrowing, and overall economic health. The second-quarter report follows a strong first quarter in which the company exceeded expectations, and it comes amid evolving interest rate expectations and resilient U.S. economic data. Strong performance here often influences sector sentiment and broader market moves. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Earnings Expectations

Wall Street consensus calls for earnings per share of $5.44 in the second quarter of 2026. This figure is 9.7% higher than the $4.96 reported in the same period last year. Revenue is projected to show mid-single-digit growth, supported by higher net interest income and fee-based activities. Analysts highlight potential strength in consumer banking and investment banking fees. The company has surpassed consensus EPS estimates in each of the last four quarters. Historical patterns show the stock often reacts to beats or misses in net interest margin and credit provisions. Key metrics under scrutiny include tangible book value per share, return on tangible common equity, and any updates to full-year guidance.

Market Reaction and Investor Sentiment

Sentiment heading into the report remains cautiously optimistic, supported by the bank’s consistent earnings beats and solid balance sheet. Traders are watching for any signals on interest rate sensitivity and credit trends. Pre-earnings positioning often focuses on volatility around the release, with options activity reflecting uncertainty about the magnitude of any revenue or margin surprises. Broader market conditions, including Treasury yields and economic data releases, will also shape the immediate reaction. From what I see, one thing that stands out is how pre-earnings options activity has priced in measured moves rather than extreme swings.

Forward Outlook and Key Factors to Monitor

Following the release, investors will parse management commentary for updates on net interest income outlook and deposit trends. Guidance on loan growth across consumer and commercial segments will provide clues about demand. Credit quality metrics, including net charge-offs and allowance for credit losses, remain important in the current environment.

Additional focus areas include investment banking pipeline strength and asset management fee performance. Any comments on capital return plans or share repurchase activity could influence long-term investor views. Broader economic indicators, such as employment data and inflation readings, will help frame expectations for the remainder of the year. I’m watching this closely because updates on deposit costs and loan demand often set the tone for the sector.

Enhancing My Research with AI Tools

In preparing for earnings seasons like this one, I sometimes turn to Tickeron’s AI Screener to quickly filter peers and spot patterns in banking stocks. It lets me scan for technical signals, fundamentals, and volatility metrics that might otherwise take hours to compile manually. The tool has helped me surface comparable names and confirm whether JPMorgan’s metrics stand out relative to the group. It is not a replacement for fundamental work, but it adds an efficient layer when I want to cross-check ideas before the report drops.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: JPM

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


JPM's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for JPM turned positive on August 12, 2026. Looking at past instances where JPM's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 30, 2026. You may want to consider a long position or call options on JPM as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where JPM advanced for three days, in of 359 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 319 cases where JPM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where JPM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

JPM broke above its upper Bollinger Band on July 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 19, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. JPM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: JPM's P/B Ratio (2.730) is slightly higher than the industry average of (1.977). P/E Ratio (15.557) is within average values for comparable stocks, (16.541). Projected Growth (PEG Ratio) (1.776) is also within normal values, averaging (1.641). JPM has a moderately low Dividend Yield (0.016) as compared to the industry average of (0.025). P/S Ratio (5.086) is also within normal values, averaging (4.413).

Notable companies

The most notable companies in this group are JPMorgan Chase & Co (NYSE:JPM), Bank of America Corp (NYSE:BAC), HSBC Holdings PLC (NYSE:HSBC), Wells Fargo & Co (NYSE:WFC), Citigroup (NYSE:C), Barclays PLC (NYSE:BCS).

Industry description

Major banks are among the biggest companies in the world, often times with global reach and market capitalizations in the multi-billions. Large banks often have multiple arms spanning different disciplines, from deposits, to investment banking, to wealth management and insurance. The biggest banks often have key competitive advantages over smaller players in the industry in terms of brand recognition, cost of capital, and efficiency. Think J.P. Morgan, Bank of America, Wells Fargo, and Citigroup.

Market Cap

The average market capitalization across the Major Banks Industry is 220.18B. The market cap for tickers in the group ranges from 1.04M to 965.21B. JPM holds the highest valuation in this group at 965.21B. The lowest valued company is BACRP at 1.04M.

High and low price notable news

The average weekly price growth across all stocks in the Major Banks Industry was 2%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 24%. NTB experienced the highest price growth at 4%, while BCS experienced the biggest fall at 1%.

Volume

The average weekly volume growth across all stocks in the Major Banks Industry was -36%. For the same stocks of the Industry, the average monthly volume growth was -21% and the average quarterly volume growth was -50%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 68
P/E Growth Rating: 29
Price Growth Rating: 40
SMR Rating: 7
Profit Risk Rating: 19
Seasonality Score: -24 (-100 ... +100)
View a ticker or compare two or three
JPM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a major bank

Industry MajorBanks

Profile
Details
Industry
Major Banks
Address
383 Madison Avenue
Phone
+1 212 270-6000
Employees
309926
Web
https://www.jpmorganchase.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.